Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025)
Invivyd (IVVD) reported Other Accumulated Expenses of $52000.0 for Q4 2025, up 92.59% on a YoY basis from $27000.0 in Q4 2024, and up 62.5% quarter-over-quarter from $32000.0 in Q3 2025.
Invivyd (IVVD) Other Accumulated Expenses (2022 - 2025) Analysis & Trends
Invivyd has reported Other Accumulated Expenses for 4 years, with the latest figure at $52000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses rose 92.59% year-over-year to $52000.0; the trailing twelve-month figure through Dec 2025 stood at $52000.0 (up 92.59% YoY), and the FY2025 full-year result was $52000.0, up 92.59% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $52000.0, up from $32000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $58000.0 in Q2 2022, with the low at $20000.0 in Q3 2024.
- Historically, Other Accumulated Expenses has averaged $37666.7 across 4 years, with a median of $35000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses slumped 49.06% — and 2025, when it surged 92.59%.
- Invivyd's Other Accumulated Expenses stood at $44000.0 in 2022, then fell by 20.45% to $35000.0 in 2023, then slipped by 22.86% to $27000.0 in 2024, then surged by 92.59% to $52000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $52000.0 (Q4 2025), $32000.0 (Q3 2025), and $26000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 27,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Sep 30, 2023 | 27,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 58,000.00 |
| Dec 31, 2022 | 44,000.00 |
| Sep 30, 2022 | 53,000.00 |
| Jun 30, 2022 | 58,000.00 |